Abstract
AimTo identify differentially methylated positions (DMPs) and regions (DMRs) that predict response to Methotrexate (MTX) in early rheumatoid arthritis (RA) patients.Materials and methodsDNA from baseline peripheral blood mononuclear cells was extracted from 72 RA patients. DNA methylation, quantified using the Infinium MethylationEPIC, was assessed in relation to response to MTX (combination) therapy over the first 3 months.ResultsBaseline DMPs associated with response were identified; including hits previously described in RA. Additionally, 1309 DMR regions were observed. However, none of these findings were genome-wide significant. Likewise, no specific pathways were related to response, nor could we replicate associations with previously identified DMPs.ConclusionNo baseline genome-wide significant differences were identified as biomarker for MTX (combination) therapy response; hence meta-analyses are required.
Highlights
Baseline differentially methylated positions (DMPs) associated with response were identified; including hits previously described in rheumatoid arthritis (RA)
No specific pathways were related to response, nor could we replicate associations with previously identified DMPs
No baseline genome-wide significant differences were identified as biomarker for MTX therapy response; meta-analyses are required
Summary
14,184 probes out of 860,599 were removed during quality control. Hereafter, 69 subjects and 846,415 probes were included. N Sex, Female (%) Age (years) Baseline DAS28 BMI (kg/m2) ACPA positive, N (%) RF positive, N (%) Smoking score, median (IQR) Treatment, N (%). We did not observe genome-wide significant differences (0.05/846,415 = 5.9 x 10−8) nor DMPs located in certain chromosomes, as can be seen from the Manhattan plot (Fig 2). To examine if certain Gene Ontology (GO) terms were enriched, pathway analysis was performed on the top 1000 most significant DMP results, all at nominal p-values
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
